Biosecurity Modernization and Innovation Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The Biosecurity Modernization and Innovation Act establishes requirements for companies that synthesize and sell nucleic acid sequences in interstate and foreign commerce to implement security protocols. Covered entities must verify buyer identity, establish purchase purposes, screen sequences against a federal list of high-risk sequences, refuse sales based on risk criteria, and report suspicious transactions to the Secretary of Health and Human Services. The bill directs the Secretary to issue guidance on compliance approaches, maintain a list of covered sequences, and submit reports to Congress on biotechnology competitiveness and national security risks.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.